Charles Sizemore

Charles Sizemore

Charles Lewis Sizemore is a market veteran of 20-plus years, dedicated to helping people achieve financial freedom through smart investing.

He holds a Master’s Degree in Finance and Accounting from the London School of Economics and a Bachelor of Business Administration in Finance with an International Emphasis from Texas Christian University in Fort Worth, Texas, where he graduated Magna Cum Laude and as a Phi Beta Kappa scholar.

As a keen market observer, economist, investment analyst, and prolific writer, Charles has been a repeat guest on Fox Business, has been quoted in Barron’s Magazine, and has been featured in numerous well-reputed publications and financial websites, including MarketWatch, TheStreet.com, MSN Money, Seeking Alpha, Stocks, Futures, and Options magazine, The Daily Reckoning, Benzinga, Minyanville, and Investment International.

While Charles enjoys playing basketball and his grandfather’s old saxophone his passion lies in finding investment opportunities that become safe havens for investors navigating this age of chaos.

Learn more about Charles and The Freeport Society’s premium services.

Recent Articles

10 Market Predictions for the Rest of 2015

The first half of 2015 has been a wild and crazy ride. Here's a look at 10 predictions for the final few months.

DPS Stock: Dr Pepper Still Is a Buy, Even Without the BodyArmor Hype

Dr Pepper's investment in the sports drink BodyArmor doesn't make it a threat to Pepsi's Gatorade or even Coca-Cola's Powerade, but that's not to say DPS stock can't juice your returns.

Does Berkshire Hathaway Make the Cut as a Retirement Stock? (BRK.B)

Warren Buffett has more intelligence as an investor in his pinky than most do in their entire body, but that doesn't make Berkshire Hathaway an ideal stock to bank on for retirement.

KMI Stock: Kinder Morgan a Steal After a Year of Battering

Kinder Morgan (KMI) has been hit by low crude prices, but KMI stock is a dividend-raising monster and a solid buy at current prices.

Health Care REIT: Slow and Steady Wins the Race

Health Care REIT has another very decent quarter. Does HCN stock warrant a look?